Non-CME Product Showcase

Discussion of Brukinsa For Adult Patients With Mantle Cell Lymphoma (MCL) Who Have Received At Least One Prior Therapy

September 25, 2020
11:45 AM EDT

Join us for a valuable discussion on the trial data for newly-approved BRUKINSATM in mantle cell lymphoma (MCL), as well as a review of it’s dosage and administration. Healthcare professionals including hematologist oncologists, medical oncologists, pharmacists, PAs, NPs, and RNs are encouraged to participate in this valuable dialogue.

Speaker: Lori Leslie, MD, Director, indolent lymphoma and CLL research programs, John Theurer Cancer Center

Please RSVP to Carl Majeski at 570-793-6034 or email carl.majeski@beigene.com.


Click here to enter the Non-CME Product Showcase Presentation.
Dial In Number: 888-788-0099
Meeting ID: 942 5659 6841
Passcode: 690028


Click here to view the Non-CME Product Show Case Flyer and to learn more about Brukinsa

Our Corporate Members

Pennsylvania Society of Oncology and Hematology
777 East Park Drive, PO Box 8820
Harrisburg, PA 17105-8820
(717) 558-7750, ext. 1587
info@psoh.org

This website brought to you by:

Website design by Sister Webs Design Studio, where 5% of profits are donated to women's cancer funds

Our Corporate Members